October 23, 2023
Now available PAZOPANIB
PAZOPANIB is a kinase inhibitor indicated for the treatment of adults with:
- advanced renal cell carcinoma (RCC)
- advanced soft tissue sarcoma (STS) who have received prior chemotherapy
Please see full prescribing information here.
